McElwee Frederick, Cole Amanda, Kaliappan Gomathi, Masters Andrea, Steuten Lotte
Office of Health Economics, 2nd Floor Goldings House, Hay's Galleria, 2 Hay's Lane, London, SE1 2HB, UK.
Health Economics Research Centre, University of Oxford, Oxford, UK.
Appl Health Econ Health Policy. 2025 Apr 2. doi: 10.1007/s40258-025-00960-1.
Scientific advancements offer significant opportunities for better patient outcomes, but also present new challenges for value assessment, affordability and access. Alternative payment models (APMs) can offer solutions to the ensuing payer challenges. However, a comprehensive framework that matches the spectrum of challenges with the right solution, and places them within a framework for implementation, is currently missing. To fill this gap, we propose evidence-based steps for the effective selection and implementation of APMs. First, contracting challenges should be identified and mapped to potential APM solutions. We developed a decision guide that can serve as a starting point to articulate core problems and map these to APM solutions. The main problem categories identified are: budget impact and uncertainty, value uncertainty, and the scope of value assessment and negotiation. Sub-categories include affordability, uncertainty of effectiveness, and patient heterogeneity, which map onto APM solutions such as outcome-based agreements, instalments, and subscription models. Just as important are the subsequent identification and assessment of the feasibility of potential solutions as well as collaboration to reach agreement on the terms of the APM and lay the groundwork for effective implementation. We adduce recent examples of APM implementation as evidence of how commonly cited implementation barriers can be overcome by applying pragmatic design choices and collaboration. This step-by-step framework can aid payers and manufacturers in the process of effectively identifying, agreeing on, and implementing APMs to advance patient access to cost-effective medicines, while at the same time providing appropriate incentives to support future innovation.
科学进步为改善患者治疗效果提供了重大机遇,但也给价值评估、可负担性和可及性带来了新挑战。替代支付模式(APMs)可为随之而来的支付方挑战提供解决方案。然而,目前缺少一个将一系列挑战与正确解决方案相匹配,并将它们置于一个实施框架内的综合框架。为填补这一空白,我们提出基于证据的步骤,以有效选择和实施替代支付模式。首先,应识别签约挑战并将其与潜在的替代支付模式解决方案进行匹配。我们制定了一份决策指南,可作为阐明核心问题并将其与替代支付模式解决方案进行匹配的起点。所确定的主要问题类别包括:预算影响和不确定性、价值不确定性以及价值评估和谈判的范围。子类别包括可负担性、有效性的不确定性以及患者异质性,它们对应于基于结果的协议、分期付款和订阅模式等替代支付模式解决方案。同样重要的是随后对潜在解决方案的可行性进行识别和评估,以及通过合作就替代支付模式的条款达成一致,并为有效实施奠定基础。我们列举了近期替代支付模式实施的例子,以证明通过应用务实的设计选择和合作,可以克服常见的实施障碍。这个循序渐进的框架可以帮助支付方和制造商有效地识别、商定和实施替代支付模式,以促进患者获得具有成本效益的药品,同时提供适当的激励措施以支持未来的创新。